Non-statin cholesterol drugs on every 2026 California Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in California cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | HealthSpring Assurance Rx$0.00/moS5617-158 | Wellcare Value Script$5.70/moS4802-163 | Wellcare Classic$6.20/moS4802-094 | HealthSpring Extra Rx$70.60/moS5617-382 | SilverScript Choice$103.60/moS5601-064 | Humana Value Rx Plan$104.60/moS5884-211 | AARP Medicare Rx Saver from UHC$109.40/moS5921-376 | Humana Basic Rx Plan$132.20/moS5884-114 | AARP Medicare Rx Preferred from UHC$165.40/moS5921-413 | Humana Premier Rx Plan$172.90/moS5884-178 | Blue Shield Rx Plus$199.70/moS2468-003 | Blue Shield Rx Enhanced$227.80/moS2468-004 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ezetimibegeneric Zetia | Tier 210%QL 30/30d | Tier 440% | Tier 431% | Tier 317%QL 30/30d | Tier 433% | Tier 318%QL 30/30d | Tier 317%QL 30/30d | Tier 325%QL 30/30d | Tier 2$10.00QL 30/30d | Tier 3$45.00QL 30/30d | Tier 319% | Tier 2$7.00 |
| Repathaevolocumab | Tier 3PA25%QL 6/28d | Not covered | Not covered | Tier 3PA17%QL 6/28d | Tier 3PA18% | Tier 3PA18%QL 3/28d | Tier 3PA17%QL 3/28d | Tier 3PA25%QL 3/28d | Tier 315%QL 3/28d | Tier 3PA$45.00QL 3/28d | Tier 3PA19% | Tier 3PA19% |
| Praluentalirocumab | Not covered | Tier 3PA25% | Tier 3PA25% | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| Nexletolbempedoic acid | Tier 3PA25%QL 30/30d | Tier 3PA25% | Tier 3PA25% | Tier 3PA17%QL 30/30d | Tier 318%QL 30/30d | Tier 3PA18%QL 30/30d | Tier 3PA17%QL 30/30d | Tier 3PA25%QL 30/30d | Tier 3PA15%QL 30/30d | Tier 3PA$45.00QL 30/30d | Not covered | Not covered |
| Nexlizetbempedoic acid and ezetimibe | Not covered | Not covered | Not covered | Not covered | Tier 318%QL 30/30d | Tier 3PA18%QL 30/30d | Tier 3PA17%QL 30/30d | Tier 3PA25%QL 30/30d | Tier 3PA15%QL 30/30d | Tier 3PA$45.00QL 30/30d | Not covered | Not covered |
| fenofibrategeneric Tricor | Tier 210% | Tier 2$3.00 | Tier 325% | Tier 2$5.00 | Tier 2$7.00 | Tier 2$0.00QL 30/30d | Tier 2$7.00 | Tier 325%QL 30/30d | Tier 2$10.00 | Tier 2$4.00QL 30/30d | Tier 2$7.00 | Tier 2$7.00 |
| Vascepaicosapent ethyl | Not covered | Tier 440% | Tier 431% | Not covered | Tier 433% | Tier 318%QL 120/30d | Tier 317% | Tier 325%QL 120/30d | Tier 315% | Tier 3$45.00QL 120/30d | Not covered | Not covered |
| icosapent ethylgeneric Vascepa | Tier 429% | Tier 440% | Tier 431% | Tier 430% | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Tier 449%QL 4/1d | Tier 437%QL 4/1d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.